J.-P. Machiels

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

J.-P. Machiels, C. René Leemans, Wojciech Golusiński et al. · Annals of Oncology · 2020 · 865 citations · Full text

Medicine, Oncology, Otolaryngology +12

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma

Chris Nutting, Carla M.L. van Herpen, Aisha Miah et al. · Annals of Oncology · 2009 · 147 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Emmanuel Seront, Sylvie Rottey, Brieuc Sautois et al. · Annals of Oncology · 2012 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14

Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer

Ezra E.W. Cohen, Lisa Licitra, Barbara Burtness et al. · Annals of Oncology · 2017 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Sandra Schmitz, M.-C. Kaminsky-Forrett, Stéphanie Henry et al. · Annals of Oncology · 2012 · 77 citations · Full text

Medicine, Oncology, Metastasis +13